Saeid Bouzari

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 6

Top Topics

Escherichia Coli

Urinary Tract Infection

Silver Nanoparticles

Immune Response

Top Venues

BioImpacts : BI

Annals of clinical microbiology and antimicrobials

Drug design, development and therapy

ACS biomaterials science & engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Rezaei, Mehri Habibi, Parasoo Ehsani, Mohammad Reza Asadi Karam, Saeid Bouzari
Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections. BioImpacts : BI 14 (1) (2023)
Maryam Rezaei, Mehri Habibi, Parasoo Ehsani, Mohammad Reza Asadi Karam, Saeid Bouzari
Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections. BioImpacts : BI 14 (1) (2023)
Erfaneh Jafari, Mana Oloomi, Saeid Bouzari
Characterization of antimicrobial susceptibility, extended-spectrum β-lactamase genes and phylogenetic groups of Shigatoxin producing Escherichia coli isolated from patients with diarrhea in Iran. Annals of clinical microbiology and antimicrobials 20 (1) (2021)
Sara Hasanzadeh, Mehdi Farokhi, Mehri Habibi, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Fatemeh Rezaei, Mohammad Reza Asadi Karam, Saeid Bouzari
Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection. ACS biomaterials science & engineering 6 (8) (2020)
Neda Moazzezy, Mohammad Reza Asadi Karam, Sima Rafati, Saeid Bouzari, Mana Oloomi
A Synthetic Peptide 2Abz23S29 Reduces Bacterial Titer and Induces Pro-Inflammatory Cytokines in a Murine Model of Urinary Tract Infection. Drug design, development and therapy 14 (2020)
Maryam Golshani, Nafise Vaeznia, Mehdi Sahmani, Saeid Bouzari
In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b. Clinical and experimental vaccine research 5 (1) (2016)